Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction | Zendy

Daniel Sürder | Zendy; Robert Manka | Zendy; Viviana Lo Cicero | Zendy; Tiziano Moccetti | Zendy; Kaspar Rufibach | Zendy; Sabrina Soncin | Zendy; Lucia Turchetto | Zendy; Marina Radrizzani | Zendy; Giuseppe Astori | Zendy; Juerg Schwitter | Zendy; Paul Erné | Zendy; Michel Züber | Zendy; Christoph Auf der Maur | Zendy; Peiman Jamshidi | Zendy; Oliver Gaemperli | Zendy; Stephan Windecker | Zendy; Aris Moschovitis | Zendy; Andreas Wahl | Zendy; Ines Bühler | Zendy; Christophe Wyss | Zendy; Sebastian Kozerke | Zendy; Ulf Landmesser | Zendy; Thomas F. Lüscher | Zendy; Roberto Corti | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction

Author(s) -

Daniel Sürder,

Robert Manka,

Viviana Lo Cicero,

Tiziano Moccetti,

Kaspar Rufibach,

Sabrina Soncin,

Lucia Turchetto,

Marina Radrizzani,

Giuseppe Astori,

Juerg Schwitter,

Paul Erné,

Michel Züber,

Christoph Auf der Maur,

Peiman Jamshidi,

Oliver Gaemperli,

Stephan Windecker,

Aris Moschovitis,

Andreas Wahl,

Ines Bühler,

Christophe Wyss,

Sebastian Kozerke,

Ulf Landmesser,

Thomas F. Lüscher,

Roberto Corti

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.112.001035

Subject(s) - medicine , ejection fraction , myocardial infarction , cardiology , ventricle , confidence interval , clinical endpoint , ventricular remodeling , infarction , heart failure , randomized controlled trial

Intracoronary administration of autologous bone marrow-derived mononuclear cells (BM-MNC) may improve remodeling of the left ventricle (LV) after acute myocardial infarction. The optimal time point of administration of BM-MNC is still uncertain and has rarely been addressed prospectively in randomized clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research